Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
about
Ig Constant Region Effects on Variable Region Structure and FunctionInvestigational drugs to treat methicillin-resistant Staphylococcus aureusWill there ever be a universal Staphylococcus aureus vaccine?Neutrophil-Mediated Phagocytosis of Staphylococcus aureusPolysaccharide intercellular adhesin in biofilm: structural and regulatory aspectsAntibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogensTargeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infectionSynthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogensAntibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functionsMicrobiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye.Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.Why antibodies disobey the Hippocratic Oath and end up doing harm: a new clue.Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy.Isolation of highly active monoclonal antibodies against multiresistant gram-positive bacteria.Role of a putative polysaccharide locus in Bordetella biofilm development.Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosaminePoly-N-acetylglucosamine expression by wild-type Yersinia pestis is maximal at mammalian, not flea, temperatures.Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis.Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract.Extended-spectrum antibodies protective against carbapenemase-producing EnterobacteriaceaeBordetella biofilms: a lifestyle leading to persistent infectionsAdvances in MRSA drug discovery: where are we and where do we need to be?Staphylococcal biofilmsEfficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens.A Poly-N-acetylglucosamine-Shiga toxin broad-spectrum conjugate vaccine for Shiga toxin-producing Escherichia coli.Magic bullets for the 21st century: the reemergence of immunotherapy for multi- and pan-resistant microbes.Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies.Candida antigens and immune responses: implications for a vaccine.Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.Novel targets for antibiotics in Staphylococcus aureus.Label-free electrical sensing of bacteria in eye wash samples: A step towards point-of-care detection of pathogens in patients with infectious keratitis.The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAGAn engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.Monoclonal antibody raised against PNAG has variable effects on static S. epidermidis biofilm accumulation in vitro.Structural basis for antibody targeting of the broadly expressed microbial polysaccharide poly-N-acetyl glucosamine.Workshop on immunizations in older adults: identifying future research agendas.
P2860
Q26766449-5624DCE9-7D00-4C93-B888-861A8784A2ADQ26780246-72641B4B-ACA3-4779-B3F0-08788F01BCEFQ26824837-471EA36D-CBCE-465C-9B08-15F7DE998D07Q27025128-E941DADC-3729-4C45-9046-8097F665E80CQ28084004-E6A1B1A0-2BDD-487C-BE83-99DAE823F18BQ30415823-0489F531-3D09-420E-8E48-ACA8B9D1B8DDQ30419079-A8E631A9-5252-45D6-B4CD-7C1EB881067FQ33613913-5B0D6149-F0CE-44D6-9C65-214E02E2C66AQ33719836-E3437308-9FB0-46CE-86FA-E78A5E3DC8CFQ33733443-2ECE7F51-CF5E-4DB2-BC39-1968C5C89537Q34059043-0FBE9657-7EF6-42D7-AF5A-F6ACD5525B25Q34090161-37983B66-6B15-40C1-926A-6457BE0B6912Q34090255-AF4F7F88-2C53-4587-90E7-DEF320DF2684Q34450382-9DAA9D64-992C-47A9-A046-9B01FA167BFEQ34483544-5B176FD9-8F3A-4EAB-902C-EDB4EE0350C7Q35112655-B397098F-2111-460A-BB76-68F30CAF3F9CQ35634478-37F06873-1DFE-4D88-B653-7592EB041A66Q35778177-E1E86BC7-B0B3-40B1-B0E5-C914EC089081Q35913664-D10A27E9-83A1-49C7-95D5-EE4C686A2530Q36165469-15BA6DB1-E912-43FC-A5AC-6EB30988FB51Q36191651-65B5118A-541D-4FE5-868C-2A5577D27FDCQ36213353-DAD50D40-9CF3-4A8C-BE6D-17549612D943Q36314818-8ACD8046-5F93-46AC-ADE6-D9D097731204Q36684178-C08BD89D-6D98-4634-AACE-84C385F8E426Q36794136-4095C547-4F20-4BE3-B66C-0F673C6B79E9Q37112508-EA5EA9CB-1A1A-41D5-A703-9FDF6E1018F6Q37153224-0B8B4CA0-5A4A-4528-9673-355BF242AC05Q37561334-5857A453-2CDB-42C0-B1FC-0096E1D19F2CQ37687820-77DEFE82-1ACE-453C-BD16-5B3DCDA4A9BFQ38035276-CE9591EF-0644-4526-9781-F5BA2008C741Q38166786-241D6B43-9D29-439A-8BD2-9259470B1330Q38222636-6EF34561-CF15-456E-A5D2-B6D7789AF9F6Q38883497-0A6265EC-2E12-4DCE-B1EB-502CB11FF243Q40149893-62D6FDBB-0EF7-44D1-8E77-9FA384ED46CCQ40405849-19B420F8-AF9F-4D60-A6C6-D6F3E0955F27Q40776497-42BD8853-CCE1-4ED4-A425-E6DE2DB23AFEQ42906503-B9A32316-8ADC-4F64-9C78-32BCA23D7A5CQ43133207-F1E6A3EC-547D-4B59-99B8-FA1649D075CBQ49960408-FF10A1A9-0BF4-460B-8A67-5A0B386DE222Q51774517-1C82A94B-CA86-46BA-ABB8-E61715D84715
P2860
Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@ast
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@en
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@nl
type
label
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@ast
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@en
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@nl
prefLabel
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@ast
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@en
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@nl
P2093
P2860
P1476
Characterization of the opsoni ...... ride poly-N-acetylglucosamine.
@en
P2093
Casie Kelly-Quintos
Donald Goldmann
Gerald B Pier
Lisa A Cavacini
Marshall R Posner
P2860
P304
P356
10.1128/IAI.74.5.2742-2750.2006
P407
P577
2006-05-01T00:00:00Z